On Jan 5, 2022 Innate Pharma closed a Post-IPO Debt round and raised €28,700,000 from BNP Paribas, Societe Generale, featuring lead investors .
About the company: Innate Pharma is located at France, Europe.
“”
Company website: http://www.innate-pharma.com